Susan L. Uprichard

May 7, 2024 | virologyj.biomedcentral.com | Shuchen Feng |Gail Reid |Nina M. Clark |Amanda Harrington |Susan Baker |Susan L. Uprichard

All SARS-CoV-2 positive nasopharyngeal swab specimens were obtained at our medical center for clinical purposes, including those taken from patients who were hospitalized for COVID-19, immunosuppressed, and/or sampled multiple times, using a protocol approved by the Loyola University Health Sciences Campus Institutional Review Board (IRB #214,365). We sequenced 210 SARS-CoV-2 positive nasopharyngeal swab RNA samples from 192 patients.